These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Role of leukotrienes in antimicrobial host defense of the lung. Peters-Golden M; Coffey M Clin Rev Allergy Immunol; 1999; 17(1-2):261-9. PubMed ID: 10436871 [No Abstract] [Full Text] [Related]
26. Leukotrienes in asthma and allergic rhinitis. Stechschulte DJ N Engl J Med; 1990 Dec; 323(25):1769-70. PubMed ID: 2247109 [No Abstract] [Full Text] [Related]
27. Role of 5-lipoxygenase in myocardial ischemia-reperfusion injury in mice. Adamek A; Jung S; Dienesch C; Laser M; Ertl G; Bauersachs J; Frantz S Eur J Pharmacol; 2007 Sep; 571(1):51-4. PubMed ID: 17586489 [TBL] [Abstract][Full Text] [Related]
28. 5-Lipoxygenase-derived lipid mediators are not required for the development of NSAID-induced inflammatory bowel disease in IL-10-/- mice. Narushima S; DiMeo D; Tian J; Zhang J; Liu D; Berg DJ Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G477-88. PubMed ID: 18048478 [TBL] [Abstract][Full Text] [Related]
31. Trypanosoma cruzi: effect of the absence of 5-lipoxygenase (5-LO)-derived leukotrienes on levels of cytokines, nitric oxide and iNOS expression in cardiac tissue in the acute phase of infection in mice. Panis C; Mazzuco TL; Costa CZ; Victorino VJ; Tatakihara VL; Yamauchi LM; Yamada-Ogatta SF; Cecchini R; Rizzo LV; Pinge-Filho P Exp Parasitol; 2011 Jan; 127(1):58-65. PubMed ID: 20599987 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological inhibition of leukotriene biosynthesis: effects on the heart conductance. Sanak M; Dropinski J; Sokolowska B; Faber J; Rzeszutko M; Szczeklik A J Physiol Pharmacol; 2010 Feb; 61(1):53-8. PubMed ID: 20228415 [TBL] [Abstract][Full Text] [Related]
33. The regulation of 5-lipoxygenase activity in rat basophilic leukemia cells. Wong A; Hwang SM; Cook MN Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():28-34. PubMed ID: 2169181 [No Abstract] [Full Text] [Related]
34. New frontiers in asthma therapy: leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Introduction. Hendeles L Pharmacotherapy; 1997; 17(1 Pt 2):1S-2S. PubMed ID: 9017782 [No Abstract] [Full Text] [Related]
35. Intracellular compartmentalization of leukotriene biosynthesis. Peters-Golden M; Brock TG Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S36-40. PubMed ID: 10673224 [No Abstract] [Full Text] [Related]
36. The discovery of the leukotrienes. Samuelsson B Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S2-6. PubMed ID: 10673217 [No Abstract] [Full Text] [Related]
37. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Dixon RA; Diehl RE; Opas E; Rands E; Vickers PJ; Evans JF; Gillard JW; Miller DK Nature; 1990 Jan; 343(6255):282-4. PubMed ID: 2300173 [TBL] [Abstract][Full Text] [Related]
38. 5-Lipoxygenase. Ford-Hutchinson AW; Gresser M; Young RN Annu Rev Biochem; 1994; 63():383-417. PubMed ID: 7979243 [No Abstract] [Full Text] [Related]
39. Interferons, interleukins, virus-host interaction: relation to leukotrienes and other lipoxygenase derivatives of the arachidonic acid. Mayer M Acta Virol; 1990 Feb; 34(1):99-107. PubMed ID: 1697728 [TBL] [Abstract][Full Text] [Related]